Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae

References

• Peterson E, Kaur P. Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Front Microbiol. 2018;9:2928.
   PubMed Web of Science ®Google Scholar
• Siddiqui MT, Mondal AH, Gogry FA, et al. Plasmid-mediated ampicillin, quinolone, and heavy metal co-resistance among ESBL-producing isolates from the Yamuna river, New Delhi, India. Antibiotics. 2020;9(11):826.
   Google Scholar
• World Health Organization. Ten threats to global health in 2019; 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
   Google Scholar
• WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva, Switzerland: WHO; 2017.
   Google Scholar
• Fasciana T, Gentile B, Aquilina M, et al. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in South of Italy. BMC Infect. Dis. 2019;19:1–10.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–1798.
   PubMed Web of Science ®Google Scholar
• Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2014;44(2):51–56.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L, Walsh TR, et al. The emerging NDM carbapenemases. Trends Microbiol. 2011;19(12):588–595.
   PubMed Web of Science ®Google Scholar
• Berrazeg M, Diene SM, Medjahed L, et al. New delhi metallo ß-lactamase around the world; an eReview using google maps. Euro Surveill. 2014;19(20):20809.
   PubMedGoogle Scholar
• Poirel L, Héritier C, Tolün V, et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15–22.
   PubMed Web of Science ®Google Scholar
• Girlich D, Bouihat N, Poirel L, et al. High rate of faecal carriage of extendedspectrum ß-lactamase and OXA-48 carbapenemase-producing enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect. 2014;20(4):350–354.
   PubMed Web of Science ®Google Scholar
• El-Kholy A, El-Mahallawy HA, Elsharnouby N, et al. Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review. Infect Drug Resist. 2021;14:1905–1920.
   PubMed Web of Science ®Google Scholar
• Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis. 2019;69(Suppl 7):S565–S575.
   PubMed Web of Science ®Google Scholar
• Win W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Colour atlas and textbook of diagnostic microbiology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 211–230.
   Google Scholar
• CLSI. 2020. Performance standards for antimicrobial susceptibility testing. 30th edition. In: CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute..
   Google Scholar
• Marchaim D, Pogue JM, Tzuman O, et al. Major variation in MICs of tigecycline in gram-negative bacilli as a function of testing method. J Clin Microbiol. 2014;52(5):1617–e1621.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G, Brown DFJ, Goldstein FW, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin Microbiol Infect. 2006;12:501– 503. .
   Google Scholar
• Ellington MJ, Kistler J, Livermore DM, et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007;59(2):321–322.
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detec- tion of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
   PubMed Web of Science ®Google Scholar
• Baker TM, Satlin MJ. The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma. 2016;57(10):2245–2258.
   PubMed Web of Science ®Google Scholar
• Kotb S, Lyman M, Ismail G, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using national healthcare–associated infections surveillance data. Antimicrob Resist Infect Control. 2020;9(1):2–2017.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205.
   PubMedGoogle Scholar
• Zafer MM, El-Mahallawy HA, Abdulhak A, et al. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann Clin Microbiol Antimicrob. 2019;18(1):40.
   PubMed Web of Science ®Google Scholar
• Khedr R, Elmahallawy H, El-swaify M, et al. Current prevalence of colistin resistance and its impact on mortality among pediatric cancer patients in Egypt. In: ECCMID conference (abstract presentation). Amsterdam, Netherlands; 2016.
   Google Scholar
• EMA/AMEG. Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health; 2021. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/updated-advice-usecolistin-products-animals-within-european-union-development-resistance-possible_en-0.pdf.
   Google Scholar
• Wang Y, Xu C, Zhang R, et al. Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study. Lancet Infect. Dis. 2020;20(10):1161–1171.
   PubMed Web of Science ®Google Scholar
• Usui M, Nozawa Y, Fukuda A, et al. Decreased colistin resistance and MCR-1 prevalence in pig-derived Escherichia coli in Japan after banning colistin as a feed additive. J Glob Antimicrob Resist. 2021;24:383–386.
   PubMed Web of Science ®Google Scholar
• Alabdullatif M, Alrehaili J. Three years of evaluation to determine reduction of antibiotic resistance in gram-negative bacteria by the saudi national action plan. IDR. 2020;13:3657–3667.
   Google Scholar
• Bandy A, Tantry B. ESBL activity, MDR, and carbapenem resistance among predominant Enterobacterales isolated in 2019. Antibiotics. 2021;10(6):744.
   Google Scholar
• Lob SH, Hackel MA, Hoban DJ, et al. Activity of ertapenem against Enterobacteriaceae in seven global regions-SMART 2012–2016. Eur J Clin Microbiol Infect Dis. 2018;37(8):1481–1489.
   PubMed Web of Science ®Google Scholar
• Fritzenwanker M, Imirzalioglu C, Herold S, et al. Treatment options for carbapenem- resistant gram-negative infections. Dtsch Arztebl Int. 2018;115(20-21):345–352.
   PubMed Web of Science ®Google Scholar